Far East Bio-Tec Co., Ltd.
Far East Bio-Tec Co., Ltd. manufactures and sells organic chlorella, spirulina, and dietary supplements. It also offers nutraceuticals/nutritional supplements, immune booster products, antiviral sprays, and pet supplements. The company was founded in 1976 and is based in Taipei, Taiwan.
Far East Bio-Tec Co., Ltd. (6886) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of June 2025: 0.024x
Based on the latest financial reports, Far East Bio-Tec Co., Ltd. (6886) has a cash flow conversion efficiency ratio of 0.024x as of June 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (NT$13.46 Million) by net assets (NT$552.89 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Far East Bio-Tec Co., Ltd. - Cash Flow Conversion Efficiency Trend (2020–2024)
This chart illustrates how Far East Bio-Tec Co., Ltd.'s cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Far East Bio-Tec Co., Ltd. Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Far East Bio-Tec Co., Ltd. ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
KINGDEE INTL SOFTWA
BE:KDIC
|
N/A |
|
Hortico S.A.
WAR:HOR
|
0.188x |
|
UNITIKA
BE:UTN
|
N/A |
|
Suno Fazendas Fiagro – Imobiliario
SA:SNFZ11
|
N/A |
|
Core AI Holdings
NASDAQ:CHAI
|
N/A |
|
Eleco PLC
LSE:ELCO
|
0.162x |
|
Eureka Capital Corp.
V:EBCD-P
|
N/A |
|
CASI PHARMAC. NEW O.N.
F:ENM
|
N/A |
Annual Cash Flow Conversion Efficiency for Far East Bio-Tec Co., Ltd. (2020–2024)
The table below shows the annual cash flow conversion efficiency of Far East Bio-Tec Co., Ltd. from 2020 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | NT$513.79 Million | NT$76.94 Million | 0.150x | +3609.35% |
| 2023-12-31 | NT$488.62 Million | NT$-2.08 Million | -0.004x | -101.72% |
| 2022-12-31 | NT$431.51 Million | NT$106.80 Million | 0.247x | +68.61% |
| 2021-12-31 | NT$365.70 Million | NT$53.68 Million | 0.147x | -24.52% |
| 2020-12-31 | NT$390.39 Million | NT$75.92 Million | 0.194x | -- |